Codes / ICD10CM / O36.0121

O36.0121 Maternal care for anti-D [Rh] antibodies, second trimester, fetus 1

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Maternal care for anti-D [Rh] antibodies, second trimester, fetus 1
  • ICD Code: O36.0121

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the second trimester who has anti-D (Rh) antibodies and is carrying a single fetus. The focus is on managing the risk of hemolytic disease of the fetus and newborn (HDFN), which can occur if the fetus is Rh-positive. Care includes assessing antibody levels, fetal monitoring, and planning for interventions to prevent or treat complications related to Rh incompatibility.

Causes

The presence of anti-D antibodies typically results from prior exposure to Rh-positive blood, such as during a previous pregnancy with an Rh-positive fetus, blood transfusion, or trauma. These antibodies can cross the placenta and attack the red blood cells of an Rh-positive fetus, leading to hemolysis.

Risk Factors

  • Previous pregnancy with an Rh-positive fetus
  • Blood transfusion with Rh-positive blood
  • Trauma or procedures during pregnancy that may cause fetal-maternal blood mixing
  • Lack of Rh immunoglobulin (RhoGAM) administration after sensitizing events

Symptoms

  • Usually asymptomatic in the mother; symptoms may manifest in the fetus as anemia, jaundice, or hydrops fetalis
  • Maternal symptoms are rare unless complications like preeclampsia occur

Diagnosis

Blood typing and antibody screening to detect anti-D antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Fetal blood sampling may be performed if severe HDFN is suspected.

Treatment Options

  • Monitoring of antibody titers and fetal well-being
  • Administration of Rh immunoglobulin (if appropriate)
  • Intrauterine transfusions for severe fetal anemia
  • Planning for delivery timing and neonatal care

Prognosis and Follow-Up

With proper monitoring and intervention, outcomes for both mother and fetus are generally favorable. Follow-up includes continued fetal surveillance and postpartum care for the newborn.

Complications

  • Severe fetal anemia
  • Hydrops fetalis
  • Kernicterus (bilirubin-induced brain damage)
  • Increased risk of preterm birth

Lifestyle & Prevention

  • Ensure Rh immunoglobulin is administered after sensitizing events
  • Avoid unnecessary invasive procedures during pregnancy
  • Maintain regular prenatal care

When to Seek Professional Help

Seek immediate medical attention if experiencing vaginal bleeding, reduced fetal movement, or signs of preeclampsia.

Tips for Medical Coders

Document the trimester (second trimester) and number of fetuses (fetus 1) to support accurate coding. Include details of antibody monitoring, fetal assessments, and any interventions performed.

Book a walkthrough

O36.0121 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.